Serum tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and IL-17 levels are associated with disease activity in systemic lupus erythematosus patients with and without nephritis
Serum tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and IL-17 levels are associated with disease activity in systemic lupus erythematosus patients with and without nephritis
نویسندگان: محمد رضا جعفری نخجوانی , سیما عابدی آذر , امیر قربانی حق جو , نیلوفر اسماعیلی کردلر , طلا پورلک , سپیده زنونی واحد
کلمات کلیدی: Systemic lupus erythematosus, Lupus biomarkers, Nephritis, Chronicity index, Proteinuria, Activity index, End-stage renal disease, Dialysis, Renal replacement
نشریه: 0 , 3 , 8 , 2019
| نویسنده ثبت کننده مقاله |
امیر قربانی حق جو |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات بیوتکنولوژی(زیست فناوری) |
| کد مقاله |
72757 |
| عنوان فارسی مقاله |
Serum tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and IL-17 levels are associated with disease activity in systemic lupus erythematosus patients with and without nephritis |
| عنوان لاتین مقاله |
Serum tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and IL-17 levels are associated with disease activity in systemic lupus erythematosus patients with and without nephritis |
| ناشر |
6 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
Journal of Renal Injury Prevention |
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Introduction: Lupus nephritis (LN) is one of the most severe signs of systemic lupus erythematosus
(SLE) and rapid diagnosis of kidney damage remains an important concern for LN.
Objectives: The aim of this study was to investigate the association of the serum levels of tumor
necrosis factor-like weak inducer of apoptosis (TWEAK) and interleukin 17 (IL-17) with SLE
severity, renal involvement, and other clinical manifestations in lupus patients.
Patients and Methods: In order to determine a better biomarker for the detection of renal damage,
this study evaluated the ability of serum TWEAK (sTWEAK) and IL-17 in lupus patients with
(n=25) and without (n=25) nephritis and healthy controls (n=39). Moreover, it compared the
levels of these cytokines with disease activity and chronicity as well as traditional serum markers
including complement C3 and C4, creatinine, and proteinuria in lupus patients.
Results: Increased levels of sTWEAK and IL-17 were observed in SLE and LN groups compared to
healthy controls and non-LN groups, respectively. Significant positive associations were observed
between serum TWEAK and IL-17 levels and systemic lupus erythematosus disease activity
index (SLEDAI), proteinuria, nephritis activity index, and some clinical manifestations (P<0.05).
Discriminating the ability of the studied cytokines were not better than the utility of any markers
individually.
Conclusion: The serum levels of TWEAK and IL-17 in the SLE and LN groups were significantly
higher than the control group and both markers were indicative of the renal disease severity;
therefore, they could possibly indicate renal involvement in the lupus patients. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| 91137979.pdf | 1399/07/14 | 990351 | دانلود |